Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians

Atherosclerosis

Volumn 161, Issue 1, 2002, Pages 233-242

  Weyer, Christian ^a,b   Yudkin, John S ^b   Stehouwer, Coen D A ^c   Schalkwijk, Casper G ^c   Pratley, Richard E ^a   Tataranni, P Antonio ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; Ethnicity; Glucose clamp; Insulin resistance; Obesity

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; PHOSPHOLIPASE A2; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY FAT; CLAMP; CONTROLLED STUDY; CORRELATION ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOTHELIUM; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; INDIAN; INFLAMMATION; INSULIN RESISTANCE; NORMAL HUMAN; OBESITY; PREVALENCE; PRIORITY JOURNAL;

EID: 0036186652     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00626-8     Document Type: Article

References (54)

1. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link?
2. Body mass index, diabetes, and C-reactive protein among US adults
3. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role of cytokines originating from adipose tissue?
4. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women
5. Insulin action and insulinemia are closely related to the fasting complement C3, but not of acylation-stimulating protein concentration
6. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS)
7. Interleukin-6 and the acute-phase response
8. Immune mechanisms in atherosclerosis
9. Immunological mechanisms in atherosclerosis
10. NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X
11. Is type 2 diabetes a disease of the innate immune system?
12. Insulin resistance and inflammation in an evolutionary perspective: The contribution of cytokine genotype/phenotype to thriftiness
13. Adhesion molecules and inflammatory injury
14. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte count
15. Circulating adhesion molecules in disease
16. TNF-alpha and IL-4 synergistically increase vascular cell adhesion molecule-1 expression in cultured vascular smooth muscle cells
17. Tumour necrosis factor induces von Willebrand factor release in healthy humans
18. Tumor necrosis factor-α inhibits signaling from the insulin receptor
19. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease
20. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
21. Von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and non-diabetic subjects: The Hoorn study
22. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): A cohort study
23. Increased levels of soluble vascular adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: The Hoorn study
24. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk In Communities study
25. Plasma concentrations of soluble intercellular adhesion molecule 1 and risk of future myocardial infarction in apparently healthy men
26. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis
27. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria
28. The relationship between plasma glucose and insulin responses to oral glucose, LDL oxidation, and soluble intercellular adhesion molecule-1 in healthy volunteers
29. Endothelial dysfunction: Cause of the insulin resistance syndrome
30. Relationship between insulin resistance, soluble adhesion molecules, and mononuclear cell binding in healthy volunteers
31. Insulin sensitivity and haemodynamic factors in men at high and low cardiovascular risk
32. Diabetes mellitus in the Pima Indians: Incidence risk factors and pathogenesis
33. Exaggerated early insulin release and insulin resistance in a diabetes-prone population: A metabolic comparison of Pima Indians and Caucasians
34. Coronary heart disease in the Pima Indians: Electrocardiographic findings and post-mortem evidence of myocardial infarction in a population with a high prevalence of diabetes mellitus
35. Coronary heart disease prevalence and its relation to risk factors in American Indians
36. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
37. A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: Evidence for a pathogenic role of relative hyperinsulinemia
38. Diabetes mellitus: Report of a WHO study group
39. Plasma concentration of C-reactive protein is increased in Type 1 diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: Evidence for a chronic inflammation
40. Interleukin-6 is associated with insulin resistance independently of obesity
41. Role of group II secretory phospholipase A2 in atherosclerosis: Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2
42. The role of phospholipase A2 in the physiopathology of osteoarthritis
43. Elevation of phospholipase A2 protein in sera of patients with Crohn's disease and ulcerative colitis
44. Relationship of the white blood cell count to body fat: Role of leptin
45. Diabetes mellitus: A thrifty genotype rendered detrimental by progress?
46. High incidence and prevalence of rheumatoid arthritis in Pima Indians
47. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: Relation to metabolic control
48. Increased levels of soluble adhesion molecules in type 2 (non-insulin-dependent) diabetes mellitus are independent of glycemic control
49. Effects of insulin on in vitro vascular cell adhesion molecule-1 expression and in vivo VCAM-1 release
50. Endothelial dysfunction in men with small LDL particles
51. Plasma and lipoprotein cholesterol and triglyceride concentrations in the Pima Indians: Distributions differing from those in Caucasians
52. Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes
53. Diabetic kidney disease in Pima Indians
54. 24-Hour urinary albumin excretion is related to insulin action and is a familial trait in non-diabetic Pima Indians